NSE - Delayed Quote INR

Astec LifeSciences Limited (ASTEC.NS)

Compare
1,020.40
+3.50
+(0.34%)
At close: 3:30:02 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
3,724,610.00
4,581,807.00
6,281,662.00
6,765,661.00
5,548,721.00
Cost of Revenue
3,065,012.00
3,233,179.00
4,054,336.00
3,908,364.00
3,452,110.00
Gross Profit
659,598.00
1,348,628.00
2,227,326.00
2,857,297.00
2,096,611.00
Operating Expense
1,754,452.00
1,764,563.00
1,792,056.00
1,653,967.00
1,199,475.00
Operating Income
-1,094,854.00
-415,935.00
435,270.00
1,203,330.00
897,136.00
Net Non Operating Interest Income Expense
-289,960.00
-250,746.00
-166,651.00
-87,946.00
-39,666.00
Pretax Income
-1,333,257.00
-617,479.00
349,473.00
1,211,258.00
890,709.00
Tax Provision
-297,718.00
-148,569.00
93,535.00
312,432.00
240,021.00
Net Income Common Stockholders
-1,035,914.00
-469,295.00
255,649.00
898,586.00
650,489.00
Diluted NI Available to Com Stockholders
-1,035,914.00
-469,295.00
255,649.00
898,586.00
650,489.00
Basic EPS
-52.82
-23.93
13.04
45.87
33.23
Diluted EPS
-52.82
-23.93
13.04
45.85
33.21
Basic Average Shares
19,611.20
19,607.45
19,603.02
19,589.90
19,575.81
Diluted Average Shares
19,614.07
19,610.33
19,606.91
19,599.00
19,589.86
Rent Expense Supplemental
--
11,562.00
10,686.00
10,180.00
10,532.00
Total Expenses
4,819,464.00
4,997,742.00
5,846,392.00
5,562,331.00
4,651,585.00
Net Income from Continuing & Discontinued Operation
-1,035,914.00
-469,295.00
255,649.00
898,586.00
650,489.00
Normalized Income
-1,035,048.76
-468,449.03
258,629.14
883,637.88
648,450.83
Interest Income
--
1,512.00
40,492.00
2,631.00
7,848.00
Interest Expense
287,777.00
248,563.00
201,583.00
86,949.00
47,514.00
Net Interest Income
-289,960.00
-250,746.00
-166,651.00
-87,946.00
-39,666.00
EBIT
-1,045,480.00
-368,916.00
551,056.00
1,298,207.00
938,223.00
EBITDA
-661,024.00
-6,382.00
887,581.00
1,641,770.00
1,194,776.00
Reconciled Cost of Revenue
3,065,012.00
3,233,179.00
4,054,336.00
3,908,364.00
3,452,110.00
Reconciled Depreciation
384,456.00
362,534.00
336,525.00
343,563.00
256,553.00
Net Income from Continuing Operation Net Minority Interest
-1,035,914.00
-469,295.00
255,649.00
898,586.00
650,489.00
Total Unusual Items Excluding Goodwill
-1,114.00
-1,114.00
-4,069.00
20,143.00
2,790.00
Total Unusual Items
-1,114.00
-1,114.00
-4,069.00
20,143.00
2,790.00
Normalized EBITDA
-659,910.00
-5,268.00
891,650.00
1,621,627.00
1,191,986.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-248.76
-268.03
-1,088.86
5,194.88
751.83
3/31/2021 - 11/25/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers